Comorbidities of hidradenitis suppurativa (acne inversa).
about
Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin diseaseSteroidogenesis in the skin: implications for local immune functionsSpotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativaUpdate on hidradenitis suppurativa: connecting the tracts.Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities.European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.Acne inversa (Hidradenitis suppurativa): A review with a focus on pathogenesis and treatmentHiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab.The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review.Long-term efficacy of infliximab in hidradenitis suppurativa.Metformin in dermatology: an overview.Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics.Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity.The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report.Cardiovascular disease risk factors in patients with hidradenitis suppurativa.Hidradenitis suppurativa: an update on connecting the tracts.Dermato-Endocrinology: A continuously growing field with many fascinating facets!Establishment of a European Registry for hidradenitis suppurativa/acne inversa by using an open source software.Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?Descriptive Epidemiology of Hidradenitis Suppurativa in Greece: A Study of 152 Cases.Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa.Recommendations for the management of comorbidity in hidradenitis suppurativa.Thyroid autoimmunity in patients with hidradenitis suppurativa: a case-control study.Hidradenitis suppurativa association at the time of, or subsequent to, diagnosis of inflammatory bowel disease in a large U.S. patient population.Hidradenitis Suppurativa: Inside and Out.Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document.A fatal case of hidradenitis suppurativa associated with sepsis and squamous cell carcinoma.Hidradenitis Suppurativa: An Asian Perspective from a Singaporean Institute
P2860
Q26828789-5329DF17-603F-42F5-AA0E-2F70709FE69EQ26830355-F6E109AB-F252-4C79-836C-2F68040E5DC2Q28069719-C8632934-47CC-4B36-9F06-35323DD35CF9Q34780340-3F85693C-DB43-4532-B6E7-91E52E143DB3Q34982043-89A1AE79-4CE2-44D2-8048-C5B8B4754D6BQ35553032-B2F26582-547C-48DC-9A9F-A77A4D70318AQ36612696-82BF6B59-2A95-44E8-B134-4175CF36DB43Q37279315-8DB7B2EA-FA72-4FDA-BA46-8712E5582117Q37503729-4F1F482A-B149-417B-9E43-AC5CD24FFF3AQ37590677-10708551-69C8-4B2F-9F4F-B5F57AC2A020Q37991395-BE4869DD-ACC8-4F9A-B30E-4EFC236956B1Q38000638-3714D655-7F40-4409-AF1D-CE3F16029675Q38084323-26F1DB0F-1B91-460A-9B67-E53E3D27680DQ38543875-A8B5396F-A2E0-466A-8217-29CE18307368Q38665824-2409D113-E11F-4EE1-B5DB-FC0A1A7A9A79Q38863293-BBA28B53-B85D-4AA1-93BA-EA3641CE61EEQ38929328-53ADB039-E473-4DF6-974B-239A8A160DFBQ39480879-2ADEDA07-95A3-4520-9C30-2FF131A0A334Q40163694-FC2695E5-22D3-49E1-9053-30C69869465BQ40520394-5F0C9986-EE26-46DD-AFE4-9AEEAE9B2F64Q40586896-F16AD5C8-9AF5-4306-8B0F-9CF93DFE670FQ40832450-F99ACFD2-1BAE-46FD-B97C-F162DB771B84Q41196480-A74D40D6-E028-48B3-AF75-2D044C8F1010Q42724216-4DED9949-75AB-42E2-BA3A-3ED432849F4BQ44302401-C9C03536-215D-472C-95E3-66A4FF505122Q45002156-4E266F6D-CAB7-42D5-81C8-C6904EEBA9A4Q47411192-2E12BB2C-E4CD-4C8F-B217-18E4BC563AEDQ47557825-FC9118C7-10C0-4615-A6B3-1FAADE6F3C60Q47801282-8AC11A24-5CF2-474B-A2E5-F1A758753669Q50597204-0D5467CE-E5F0-4523-BF78-2EFF50056AA4Q50997833-A0CCAD28-7FE1-4572-A81E-E619DBDB25BFQ52564843-78296A3D-BB4A-473B-BDC8-6AE7BD93A9CBQ53834019-25C0F25C-6F9B-4C1D-8F8B-3880A836D2B7Q54739659-165B2E65-9B6D-46C5-91E6-5C2DCF913B10Q58602712-9074F61E-A35E-4B84-91D8-6D8225562E10
P2860
Comorbidities of hidradenitis suppurativa (acne inversa).
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comorbidities of hidradenitis suppurativa (acne inversa).
@ast
Comorbidities of hidradenitis suppurativa (acne inversa).
@en
type
label
Comorbidities of hidradenitis suppurativa (acne inversa).
@ast
Comorbidities of hidradenitis suppurativa (acne inversa).
@en
prefLabel
Comorbidities of hidradenitis suppurativa (acne inversa).
@ast
Comorbidities of hidradenitis suppurativa (acne inversa).
@en
P2860
P356
P1476
Comorbidities of hidradenitis suppurativa (acne inversa).
@en
P2093
Christos C Zouboulis
Sabine Fimmel
P2860
P356
10.4161/DERM.2.1.12490
P577
2010-01-01T00:00:00Z